Filing Details

Accession Number:
0000899243-21-020279
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-20 20:30:13
Reporting Period:
2021-05-06
Accepted Time:
2021-05-20 20:30:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588984 D Shelly Guyer C/O Invitae Corporation
1400 16Th Street
San Francisco CA 94103
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-06 27,000 $0.00 255,309 No 4 A Direct
Common Stock Disposition 2021-05-18 3,424 $27.49 251,885 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Shares issued upon settlement of a restricted stock unit award that vests in four equal installments, with 25% of the shares vesting on May 15, 2021, and 25% of the shares vesting on each of May 15, 2022, 2023 and 2024, subject to continued service with the Issuer through the applicable vesting dates.
  2. Includes an aggregate of 114,317 shares of common stock issuable pursuant to restricted stock units that have not vested.
  3. Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.